Humacyte Q3 EPS $(0.06) Beats $(0.08) Estimate, Sales $1.028M Beat $766.000K Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Humacyte (NASDAQ:HUMA) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 45.45 percent increase over losses of $(0.11) per share from the same
Humacyte (NASDAQ:HUMA) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $1.028 million which beat the analyst consensus estimate of $766.000 thousand by 34.20 percent. This is a 36.52 percent increase over sales of $753.000 thousand the same period last year.
